In August 2021, a high-ranking research executive left Lupin Inc. , a major drug company. He said he was moving to China to take care of his parents. But on his last day, he copied 128 company files before leaving. This act is now central to a legal battle. Lupin, based in India with U. S. operations in Baltimore, sued the former executive and the new company he sta...
China has been making big strides in the world of medicine. Since 2016, they've been approving new drugs at a faster pace. These drugs are called innovative because they are new and not sold anywhere else. The country's health authority, the NMPA, has been working hard to make sure these drugs get to the people who need them. Most of these new drugs are made in Chin...
Albert Bourla, the CEO of Pfizer, is set to attend a high-profile fundraiser at President Trump's golf club in Bedminster, New Jersey. The event, organized to support the pro-Trump group MAGA Inc. , aims to raise a whopping $25 million. This comes just a day after Trump sent letters to major drug companies, including Pfizer, demanding lower drug prices in the U. S. t...
The Department of Health and Human Services is making a big change. They are stopping some vaccine projects that were in the works. These projects were using mRNA technology to fight respiratory viruses like COVID-19 and the flu. The decision came from Robert F. Kennedy Jr. , the health secretary. He is known for not always agreeing with vaccines. In a statement, he...
In a surprising turn of events, Sarepta Therapeutics has chosen to defy the FDA's request to stop distributing its gene therapy drug, Elevidys. This decision comes after three patient deaths linked to the treatment. The FDA has expressed serious concerns about the safety of the drug and has asked Sarepta to halt all shipments. However, the company has refused, arguin...
Two big names in the medical world are teaming up to fight cancer. Bristol-Myers Squibb and BioNTech have struck a deal worth up to 11. 1 billion dollars. This is a huge amount of money. The deal is all about a new type of cancer treatment. This treatment uses the body's own immune system to fight tumors. It's like teaching the body to recognize and attack cancer ...
The US Department of Health and Human Services recently made a bold move. They ended a contract with Moderna. The contract was for developing an mRNA vaccine for bird flu. The reason given was that mRNA technology is not well-tested. This decision sparked a response from Pfizer's CEO, Dr. Albert Bourla. He strongly disagreed with the claim that mRNA vaccines are unde...
The head of the Health and Human Services department, Robert F. Kennedy Jr. , has recently sparked controversy. He suggested that scientists funded by the National Institutes of Health (NIH) should stop publishing in three major medical journals. The reason? He believes these journals are influenced by the pharmaceutical industry. These journals are the New Engl...
The pharmaceutical industry is undergoing a significant shift. Platform technologies are opening up new avenues for innovation in various medical fields. These technologies are not just about creating new drugs. They are about changing how drugs are developed, tested, and brought to market. Traditional methods of assessing the value of these technologies are falling ...
The recent cabinet meeting at the White House had some big news. President Trump dropped hints about upcoming tariffs. He mentioned cars, medicines, and a few other industries. He did not give a specific date, but it sounds like it will be soon. This is not the first time Trump has talked about tariffs. He has already put tariffs on steel and aluminum. He also ...